About: Jean-Baptiste Bachet

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Jean-Baptiste Bachet Goto Sponge NotDistinct Permalink

An Entity of Type : foaf:Person, within Data Space : data.idref.fr associated with source document(s)

Attributes	Values
type	Person
sameAs	Bachet, Jean-Baptiste (1976-....) Bachet, Jean-Baptiste (1976-....) Bachet, Jean-Baptiste (1976-....)
Life Event	http://www.idref.fr/092027814/birth
preferred label	Bachet, Jean-Baptiste (1976-....)
name	Jean-Baptiste Bachet
dbpedia-owl:citizenship	http://sws.geonames.org/3017382/
Language	http://lexvo.org/id/iso639-3/fra
isni:identifierValid	0000000359383096
Given name	Jean-Baptiste
familyName	Bachet
has biographical i...tion (Deprecated)	Titulaire d'une thèse de doctorat en Génétique humaine (Université de Versailles-Saint-Quentin-en-Yvelines, 2013) Thèse déposée à la Bibliothèque universitaire Necker Directeur de thèse d'exercice de médecine à l'Université de Paris (2019-....) (en 2021) Chercheur en Gastro-entérologie et hépatologie, Hôpital Pitié-Salpêtrière en 2024
gender	male
ORCID iD	0000-0003-4337-286X
Scopus ID	13205285900
is sameAs of	Bachet, Jean-Baptiste (1976-....) Bachet, Jean-Baptiste (1976-....) Bachet, Jean-Baptiste (1976-....) Bachet, Jean-Baptiste (1976-....) Bachet, Jean-Baptiste (1976-....) Bachet, Jean-Baptiste (1976-....)
is Thesis advisor of	http://www.sudoc.fr/225867095/id http://www.sudoc.fr/266116035/id http://www.sudoc.fr/255245017/id Étude de la corrélation entre la présence d’ADN tumoral circulant et le volume tumoral chez les patients avec un adénocarcinome du pancréas métastatique http://www.sudoc.fr/280732759/id http://www.sudoc.fr/24819139X/id http://www.sudoc.fr/265756081/id Modélisation statistique de la valeur pronostique d'un paramètre et proposition d'un score intégratif, application dans le cancer du colon localisé http://www.sudoc.fr/255244495/id http://www.sudoc.fr/260114499/id
is Praeses of	http://www.sudoc.fr/26878910X/id
is Author of	http://www.sudoc.fr/092033024/id http://www.sudoc.fr/177255048/id Cancer-associated fibroblast-derived annexin A6+ extracellular vesicles support pancreatic cancer aggressiveness. Circulating tumor DNA is prognostic and potentially predictive of eryaspase efficacy in second-line in patients with advanced pancreatic adenocarcinoma Current standards and new innovative approaches for treatment of pancreatic cancer Aspirin versus placebo in stage III or high-risk stage II colon cancer with PIK3CA mutation: a French randomised double-blind phase III trial (PRODIGE 50-ASPIK) Chemotherapy of metastatic colon cancer in France: A population-based study Prognosis and chemosensitivity of non-V600E BRAF mutations in metastatic colorectal carcinoma (mCRC): An AGEO French multicenter retrospective cohort. Dynamic evaluation of circulating tumour cells in patients with advanced gastric and oesogastric junction adenocarcinoma: Prognostic value and early assessment of therapeutic effects Safety, efficacy and patient-reported outcomes with trifluridine/tipiracil in pretreated metastatic colorectal cancer: results of the PRECONNECT study Tumour and stroma RNA signatures predict more accurately distant recurrence than clinicopathological factors in resected pancreatic adenocarcinoma Three Versus 6 Months of Oxaliplatin-Based Adjuvant Chemotherapy for Patients With Stage III Colon Cancer: Disease-Free Survival Results From a Randomized, Open-Label, International Duration Evaluation of Adjuvant (IDEA) France, Phase III Trial Characterization of Plasma Cell-Free DNA Integrity Using Droplet-Based Digital PCR: Toward the Development of Circulating Tumor DNA-Dedicated Assays Traitement néoadjuvant des cancers du rectum Plasma circulating tumor DNA in pancreatic adenocarcinoma for screening, diagnosis, prognosis, treatment and follow-up: A systematic review Resection of small bowel adenocarcinoma metastases: Results of the ARCAD-NADEGE cohort study Pancreatic Ductal Adenocarcinoma Arising in Young and Old Patients Displays Similar Molecular Features Erythrocyte-encapsulated asparaginase (eryaspase) combined with chemotherapy in second-line treatment of advanced pancreatic cancer: An open-label, randomized Phase IIb trial Rationale and design of the PROMETCO study: a real-world, prospective, longitudinal cohort on the continuum of care of metastatic colorectal cancer from a clinical and patient perspective Récepteurs tyrosine-kinase, voies de signalisation et tumeurs digestives Resectable pancreatic adenocarcinoma neo-adjuvant FOLF(IRIN)OX-based chemotherapy - a multicenter, non-comparative, randomized, phase II trial (PANACHE01-PRODIGE48 study) Quel avenir pour l’ADN tumoral circulant ? État des lieux et perspectives dans les cancers colorectaux, pulmonaires non à petites cellules et pancréatiques PFOLFIRINOX as induction treatment in rectal cancer patients with synchronous metastases (RCSM): Final results of the FFCD 1102 phase II trial Overweight is associated to a better prognosis in metastatic colorectal cancer: A pooled analysis of FFCD trials Adjuvant Pancreatic Cancer Management: Towards New Perspectives in 2021 PAP/REG3A favors perineural invasion in pancreatic adenocarcinoma and serves as a prognostic marker Intraductal Papillary Mucinous Carcinoma Versus Conventional Pancreatic Ductal Adenocarcinoma: A Comprehensive Review of Clinical-Pathological Features, Outcomes, and Molecular Insights Prognostic value of the early change in neutrophil-to-lymphocyte ratio in metastatic pancreatic adenocarcinoma Geriatric factors analyses from FFCD 2001-02 phase III study of first-line chemotherapy for elderly metastatic colorectal cancer patients Gene Expression Patterns of Hemizygous and Heterozygous KIT Mutations Suggest Distinct Oncogenic Pathways: A Study in NIH3T3 Cell Lines and GIST Samples Prevalence of Microsatellite Instability in Intraductal Papillary Mucinous Neoplasms of the Pancreas Copy-neutral loss of heterozygosity and chromosome gains and losses are frequent in gastrointestinal stromal tumors. 609TiPPRODIGE 50 - ASPIK French: French double blind randomised study of aspirin versus placebo in resected stage III or high risk stage II colon cancer with PIK3CA mutation Infiltrating and peripheral immune cell analysis in advanced gastric cancer according to the Lauren classification and its prognostic significance Panitumumab-based maintenance after oxaliplatin discontinuation in metastatic colorectal cancer: A retrospective analysis of two randomised trials Adjuvant chemotherapy in pancreatic cancer: state of the art and future perspectives Pancreatic cancer: French clinical practice guidelines for diagnosis, treatment and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, AFC) FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer Analysis of Base-Position Error Rate of Next-Generation Sequencing to Detect Tumor Mutations in Circulating DNA Tumor-size responses to first-line is a predictor of overall survival in metastatic colorectal cancer FOLFIRINOX as induction treatment in rectal cancer patients with synchronous metastases: Results of the FFCD 1102 phase II trial Clinical and molecular characterisation of hereditary and sporadic metastatic colorectal cancers harbouring microsatellite instability/DNA mismatch repair deficiency Predictive factors for early progression during induction chemotherapy (IC) and chemotherapy-free interval (CFI): Analysis from PRODIGE 9 trial Mismatch Repair System Deficiency Is Associated With Response to Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer Prognostic factors of BRAF V600E colorectal cancer with liver metastases: a retrospective multicentric study https://serval.unil.ch/notice/serval:BIB_6127472F994C#id http://www.sudoc.fr/248047485/id Colorectal neuroendocrine carcinomas and adenocarcinomas share oncogenic pathways. A clinico-pathologic study of 12 cases JOURNAL OF CLINICAL ONCOLOGY Volume: 37 Issue: 15 Supplement: S Meeting Abstract: 4136 Published: MAY 20 2019 RECIST and CHOI criteria in the evaluation of tumor response in patients with metastatic colorectal cancer treated with regorafenib, a prospective multicenter study LIF Drives Neural Remodeling in Pancreatic Cancer and Offers a New Candidate Biomarker Practical considerations in the use of regorafenib in metastatic colorectal cancer Prognostic Relevance of Pancreatic Adenocarcinoma (PAC) Whole-tumor Transcriptomic Subtypes and Components Prognostic value of circulating tumour DNA in metastatic pancreatic cancer patients: post-hoc analyses of two clinical trials PACpAInt: a deep learning approach to identify molecular subtypes of pancreatic adenocarcinoma on histology slides NORAD01-GRECCAR16 multicenter phase III non-inferiority randomized trial comparing preoperative modified FOLFIRINOX without irradiation to radiochemotherapy for resectable locally advanced rectal cancer (intergroup FRENCH-GRECCAR- PRODIGE trial) BRAF mutation is not associated with an increased risk of recurrence in patients undergoing resection of colorectal liver metastases RAS mutation analysis in circulating tumor DNA from patients with metastatic colorectal cancer: the AGEO RASANC prospective multicenter study BRAF Mutation Status in Circulating Tumor DNA from Patients with Metastatic Colorectal Cancer: Extended Mutation Analysis from the AGEO RASANC Study PEPCOL: a GERCOR randomized phase II study of nanoliposomal irinotecan PEP02 (MM-398) or irinotecan with leucovorin/5-fluorouracil as second-line therapy in metastatic colorectal cancer BRCA1 and RAD51C promotor methylation in human resectable pancreatic adenocarcinoma Plasma Circulating Tumor DNA in Pancreatic Cancer Patients Is a Prognostic Marker PACpAInt: a deep learning approach to identify molecular subtypes of pancreatic adenocarcinoma on histology slides Circulating tumor DNA: a help to guide therapeutic strategy in patients with borderline and locally advanced pancreatic adenocarcinoma?

Faceted Search & Find service v1.13.91 as of Aug 16 2018

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of May 14 2019, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (70 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software